Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $209,400 |
Sells | 12 | $3,233,042 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
17 Apr 2024 16:34 | RVNC | Revance Therapeutics Inc | JORDAN ERICA | Chief Commercial Officer | 16 Apr 2024 | Sale | 2,392 | 3.8028 | 9,096 | D |
19 Mar 2024 18:45 | RVNC | Revance Therapeutics Inc | SJUTS DUSTIN S | President | 18 Mar 2024 | Sale | 9,211 | 5.0425 | 46,446 | D |
19 Mar 2024 18:44 | RVNC | Revance Therapeutics Inc | MOXIE DWIGHT | CLO & GC | 18 Mar 2024 | Sale | 8,125 | 5.0426 | 40,971 | D |
19 Mar 2024 18:44 | RVNC | Revance Therapeutics Inc | SCHILKE TOBIN | CFO | 18 Mar 2024 | Sale | 9,361 | 5.0426 | 47,204 | D |
08 Mar 2024 16:33 | RVNC | Revance Therapeutics Inc | FOLEY MARK J | CEO | 06 Mar 2024 | Purchase | 30,000 | 6.98 | 209,400 | D |
07 Sep 2023 17:37 | RVNC | Revance Therapeutics Inc | MOXIE DWIGHT | SVP, GC & Secretary | 06 Sep 2023 | Sale | 11,000 | 17.064 | 187,704 | D |
07 Sep 2023 17:37 | RVNC | Revance Therapeutics Inc | MOXIE DWIGHT | SVP, GC & Secretary | 05 Sep 2023 | Sale | 23,853 | 17.8141 | 424,920 | D |
04 Aug 2023 17:07 | RVNC | Revance Therapeutics Inc | FOLEY MARK J | CEO | 03 Aug 2023 | Sale | 26,279 | 22.5713 | 593,151 | D |
05 Jul 2023 21:11 | RVNC | Revance Therapeutics Inc | SCHILKE TOBIN | CFO | 03 Jul 2023 | Sale | 1,701 | 25.04 | 42,593 | D |
05 Jul 2023 21:11 | RVNC | Revance Therapeutics Inc | FOLEY MARK J | CEO | 03 Jul 2023 | Sale | 26,279 | 24.9375 | 655,333 | D |
20 Jun 2023 16:25 | RVNC | Revance Therapeutics Inc | KOLAJA CAREY OCONNOR | Director | 15 Jun 2023 | Sale | 2,500 | 28.24 | 70,600 | D |
13 Jun 2023 20:09 | RVNC | Revance Therapeutics Inc | SJUTS DUSTIN S | President | 09 Jun 2023 | Sale | 5,000 | 30.8192 | 154,096 | D |
13 Jun 2023 20:09 | RVNC | Revance Therapeutics Inc | FOLEY MARK J | CEO | 09 Jun 2023 | Sale | 31,279 | 30.7212 | 960,928 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)